Home / MissionIR Articles / Transgenomic, Inc. (TBIO) Starts Presentation at 25th Annual ROTH Conference

Transgenomic, Inc. (TBIO) Starts Presentation at 25th Annual ROTH Conference

Transgenomic,  a biotechnology company, operates in three segments: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. For more information, visit the company’s Web site: http://www.transgenomic.com

Let us hear your thoughts below: